| Date Filed | Type | Description |
| 06/09/2023 |
4
| Barat Stephen (Senior VP of Therapeutics) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Sold 888 shares
@ $0.8, valued at
$710.4 |
|
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/13/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/13/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/13/2022 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/13/2022 |
4
| Godlewski Laura Lee (SVP Finance & Administration) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 09/15/2022 |
4
| KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $0.86, valued at
$3.4k
|
|
| 09/15/2022 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $0.86, valued at
$3.4k
|
|
| 09/15/2022 |
4
| McCracken Lee R. (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $0.86, valued at
$3.4k
|
|
| 09/15/2022 |
4
| HARDISON DON M (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $0.86, valued at
$3.4k
|
|
| 09/15/2022 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 8,000 options to buy
@ $0.86, valued at
$6.9k
|
|
| 08/22/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 20,000 options to buy
@ $0.94, valued at
$18.8k
|
|
| 08/22/2022 |
4
| Godlewski Laura Lee (SVP Finance & Administration) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 40,000 options to buy
@ $0.94, valued at
$37.6k
|
|
| 08/22/2022 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 60,000 options to buy
@ $0.94, valued at
$56.4k
|
|
| 08/22/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 120,000 options to buy
@ $0.94, valued at
$112.8k
|
|
| 08/22/2022 |
4
| Dubensky Thomas W. (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 8,000 options to buy
@ $0.94, valued at
$7.5k
|
|
| 08/19/2022 |
3
| Dubensky Thomas W. (Director) has filed a Form 3 on HTG MOLECULAR DIAGNOSTICS, INC |
| 07/18/2022 |
3
| L5 Capital Inc. (10% Owner) has filed a Form 3 on HTG MOLECULAR DIAGNOSTICS, INC |
| 07/01/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 23 shares
@ $1.03, valued at
$23.7 |
|
| 07/01/2022 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 29 shares
@ $1.03, valued at
$29.9 |
|
| 07/01/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 61 shares
@ $1.03, valued at
$62.8 |
|
| 06/15/2022 |
4
| Godlewski Laura Lee (SVP Finance & Administration) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.476, valued at
$476 |
|
| 06/15/2022 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.476, valued at
$476 |
|
| 06/15/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.476, valued at
$476 |
|
| 06/15/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.476, valued at
$476 |
|
| 04/04/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 23 shares
@ $1.39, valued at
$32 |
|
| 04/04/2022 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 31 shares
@ $1.39, valued at
$43.1 |
|
| 04/04/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Paid exercise price by delivering 62 shares
@ $1.39, valued at
$86.2 |
|
| 01/31/2022 |
4
| KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 8,000 options to buy
@ $2.94, valued at
$23.5k
|
|
| 01/31/2022 |
3
| KIRITSY CHRISTOPHER P (Director) has filed a Form 3 on HTG MOLECULAR DIAGNOSTICS, INC |
| 12/15/2021 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 896 shares
@ $3.5615, valued at
$3.2k
|
|
| 12/15/2021 |
4
| Godlewski Laura Lee (VP Finance, Prin Acct Offr) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $3.5615, valued at
$3.6k
|
|
| 12/15/2021 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 520 shares
@ $3.5615, valued at
$1.9k
|
|
| 12/15/2021 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $3.5615, valued at
$3.6k
|
|
|